April 27, 2017 3:45 PM ET

Pharmaceuticals

Company Overview of Takeda Cambridge Ltd.

Key Executives for Takeda Cambridge Ltd.

NameBoard RelationshipsTitleAge
John Montana 17 RelationshipsChief Executive Officer and Director--
Mark Carlton Ph.D.5 RelationshipsPresident, Chief Scientific Officer and Director--
Jim Sutcliffe ACANo RelationshipsFinance Director and Company Secretary--

Takeda Cambridge Ltd. Board Members*

NameBoard RelationshipsPrimary CompanyAge
John Montana 17 RelationshipsTakeda Cambridge Ltd.--
Mark Carlton Ph.D. 5 RelationshipsTakeda Cambridge Ltd.--
Charles Cox 5 RelationshipsTakeda Cambridge Ltd.--
R. Graham Hughes Ph.D. 5 RelationshipsTechnomark Medical Ventures--
Barry Kenny 5 RelationshipsHeptares Therapeutics Ltd.--
View All Board Members

Takeda Cambridge Ltd. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
356.0K
Bonus
446.9K
Total Short Term Compensation
508.6K
Total Value of Options
8.7M
Compensation as of Fiscal Year
Takeda Cambridge Ltd. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

scPharmaceuticals, Inc. Appoints John Tucker as President, Chief Executive Officer and to the Board of Directors
April 26, 2017 2:45 PM ET
Rocky Mountain High Brands, Inc. Appoints Gerry David to the Board of Directors and Special Consultant to the Chairman
April 25, 2017 1:00 PM ET
Depomed Announces Appointment of Sharon D. Larkin as Senior Vice President, Human Resources and Administration
April 25, 2017 12:00 PM ET
Teligent, Inc. Appoints Martin Wilson to General Counsel
April 25, 2017 12:00 PM ET
Sunzen Biotech Berhad Announces Re-Designation of Mhd Nordin Bin Mohd Nor as Non-Independent Director from Independent Director
April 25, 2017 8:42 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Takeda Cambridge Ltd., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.